Table 1 Baseline characteristics of subjects who completed the intervention trial
Variables | Control (n = 30) | Chlorella(n = 33) | P-value |
|---|---|---|---|
Age | 50.9 ± 1.6 | 48.2 ± 1.4 | 0.281 |
Female/male (n) | 22/8 | 22/11 | 0.565 |
BMI (kg/m2) | 24.5 ± 0.5 | 23.9 ± 0.6 | 0.488 |
Fasting glucose (mmol/L)# | 5.5 ± 0.1 | 5.6 ± 0.1 | 0.499 |
Systolic BP (mmHg) | 120.1 ± 2.1 | 120.0 ± 2.0 | 0.981 |
Diastolic BP (mmHg) | 75.8 ± 1.3 | 76.4 ± 1.7 | 0.787 |
Lipid profiles | Â | Â | Â |
  TC (mmol/L) | 5.68 ± 0.10 | 5.60 ± 0.10 | 0.587 |
  TG (mmol/L)# | 1.49 ± 0.14 | 1.90 ± 0.23 | 0.137 |
  LDL-C (mmol/L) | 3.34 ± 0.10 | 3.18 ± 0.09 | 0.262 |
  HDL-C (mmol/L) | 1.40 ± 0.06 | 1.43 ± 0.06 | 0.914 |
  VLDL-C (mmol/L)# | 0.68 ± 0.06 | 0.86 ± 0.11 | 0.163 |
  non-HDL-C (mmol/L) | 4.26 ± 0.11 | 4.17 ± 0.11 | 0.568 |
  Apo A1 (g/L) | 1.47 ± 0.05 | 1.52 ± 0.05 | 0.493 |
  Apo B (g/L) | 1.07 ± 0.03 | 1.08 ± 0.02 | 0.886 |
  Apo E (g/L)# | 0.05 ± 0.00 | 0.06 ± 0.00 | 0.747 |